QA/AI & ML Compliance Services

Where Quality Governance Meets Digital Compliance

Person typing on laptop with overlays for AI and ethics

The rapid evolution of artificial intelligence, automation, and digital systems is reshaping regulated industries. ProPharma's QA/AI & ML Compliance Services bridge the gap between innovation and compliance, providing strategic, technical, and regulatory expertise to help you confidently adopt AI and digital technologies, while maintaining GxP integrity and global regulatory alignment.

Empowering Life Science Organizations to Govern Artificial Intelligence (AI) System Compliance Responsibly in the Digital Era.

Globally integrate compliance with AI, digital technologies, and data-driven systems with confidence, Ensuring compliance, validation, and governance are built into every step of the technology-enabled journey.

Connection

AI Strategy Development, Readiness & Implementation

Adverse event intake icon

AI Validation, GxP Compliance & Governance

Signal management icon

Data Integrity (DI) Compliance Assessments

Pharmacovigilance

Cybersecurity Readiness Audits (GxP Focused)

Business professionals collaborating

ProPharma is Your Partner for AI-Driven Quality and Compliance Excellence, delivering:

Regulatory Expertise: Experience with FDA, EMA, MHRA, PMDA, and Health Canada expectations.

Proven AI & ML Readiness Frameworks: Designed for scalable, compliant adoption.

Cross-Functional Expertise: Blending QA, data science, IT, and regulatory insights.

End-to-End Support: From strategy and validation to governance and audit readiness.

Comprehensive Support Across Your AI & ML Compliance Journey

Quality & Compliance Interconnected services are designed to ensure compliant, validated, and high-performing digital ecosystems

AI Strategy Development, Readiness & Implementation

Strengthening the foundation for AI success through structured readiness, governance, and implementation support that aligns with business and regulatory objectives.

  • Supporting clients on AI adoption and process enhancement
  • Enabling faster, smarter decision-making through integrated data and automation
  • Building internal AI capability and readiness
  • Proactively managing compliance and regulatory expectations
  • AI Readiness & Maturity Assessment
  • Digital Blueprint Development & Implementation
  • High-Impact AI Opportunity Identification
  • AI Partnership & Vendor Selection Support
  • AI Implementation Support (Business Process Optimization, OCM)
  • Governance & Performance Monitoring Frameworks
  • AI Compliance & Validation Plan

AI Validation, GxP Compliance & Governance

Ensure your AI/ML tools and algorithms meet stringent GxP, EMA, and FDA regulatory expectations through structured validation and compliance governance.

  • Validation of AI/ML applications in GxP processes (Manufacturing, QC, Clinical, etc.)
  • Assessment of algorithm training data integrity, bias, and traceability
  • Regulatory alignment verification for AI/ML systems in development and manufacturing
  • Validation Protocols & Reports
  • Algorithm Risk Assessments
  • AI/ML Lifecycle SOPs
  • Compliance Roadmaps for AI Use Cases

Data Integrity (DI) Compliance Assessments

Safeguard data trustworthiness and compliance during your digital transformation. Our DI experts assess, align compliance, and enhance your data integrity practices across systems and operations.

  • End-to-end DI audits for digital systems and applications
  • Evaluation of ALCOA+ principles, system controls, audit trails, backup/recovery
  • Map gaps vs. FDA/EMA DI guidelines and best practices
  • Development of upgrade and remediation strategies
  • Current-State DI Maturity Scorecard
  • Gap Analysis & Risk Matrix
  • Prioritized Remediation Plan
  • Updated DI SOPs
  • Support for Remediation Execution

Cybersecurity Readiness Audits (GxP Focused)

Identify and mitigate cybersecurity risks in GxP-critical digital systems to protect data integrity, ensure operational continuity, and align with global regulatory expectations.

  • Assessment of GxP digital systems (eQMS, eTMF, LIMS, MES, SCADA)
  • Evaluation of vulnerabilities and data protection measures
  • Cybersecurity Audit Report
  • GxP-Specific Cyber Risk Remediation Plan
AdobeStock_392700489

Preparing Your Organization for AI Compliance 

Successful AI adoption requires both a strong compliance strategy and a well-informed team. Complement your AI/ML quality and compliance initiatives with specialized training through ProPharma's Validation Center, including the AI in GxP Validation and Compliance course designed to help professionals navigate evolving regulatory expectations and industry best practices. 

QA/AI & ML Compliance Services

Partner with us for expert digital compliance and quality solutions. Contact ProPharma today to learn how we can support your organization’s Artificial Intelligence governance and Quality Assurance needs.

News & Insights

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their Risk Assessment Approach

October 21, 2026

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their...

Recent FDA enforcement activity is changing how MLR teams assess promotional risk. Learn why organizations are moving from defensible claims to predictive, enforcement-informed risk assessment.

AI-Readiness 101: AI Success Starts with Understanding Your Data

October 19, 2026

AI-Readiness 101: AI Success Starts with Understanding Your Data

Unlock AI success by understanding your data. Learn the foundations of AI readiness and how to build trust in your data for reliable insights.

What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine

October 13, 2026

What It Takes to Build a Successful Global Medical Information Program in Veteri...

Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Restoring Inspection Readiness and Data Integrity Following a CRO Transition - ProPharma

November 2, 2026

Restoring Inspection Readiness and Data Integrity Following a CRO Transition

A CRO transition can uncover critical gaps in clinical trial oversight, documentation, protocol deviation management, and inspection readiness. When monitoring records are incomplete and outstanding...

Case Study Accelerating Clinical Trial Activation Across Latin America - ProPharma

October 20, 2026

Accelerating Clinical Trial Activation Across Latin America

Launching clinical trials across multiple countries requires navigating varying regulatory requirements, site contracts, translations, import/export processes, and site engagement activities, all...

Infographic Flexible Resourcing Without Limits: Scaling Capabilities Across the Development Lifecycle - ProPharma

September 18, 2026

Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...

Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

December 2, 2026

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

Patients, caregivers, and healthcare professionals are increasingly turning to digital channels to seek information, share experiences, and discuss treatments. Join this webinar to explore how...

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

November 12, 2026

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

October 22, 2026

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Tired of working through lengthy regulatory documents? Join Reg Reels for a concise, video-led look at the latest pharmacovigilance developments from the EMA, FDA, and MHRA. Our experts will...

News & Insights

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their Risk Assessment Approach

October 21, 2026

From Defensible to Predictive: How High-Functioning MLR Teams Are Evolving Their...

Recent FDA enforcement activity is changing how MLR teams assess promotional risk. Learn why organizations are moving from defensible claims to predictive, enforcement-informed risk assessment.

AI-Readiness 101: AI Success Starts with Understanding Your Data

October 19, 2026

AI-Readiness 101: AI Success Starts with Understanding Your Data

Unlock AI success by understanding your data. Learn the foundations of AI readiness and how to build trust in your data for reliable insights.

What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine

October 13, 2026

What It Takes to Build a Successful Global Medical Information Program in Veteri...

Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Restoring Inspection Readiness and Data Integrity Following a CRO Transition - ProPharma

November 2, 2026

Restoring Inspection Readiness and Data Integrity Following a CRO Transition

A CRO transition can uncover critical gaps in clinical trial oversight, documentation, protocol deviation management, and inspection readiness. When monitoring records are incomplete and outstanding...

Case Study Accelerating Clinical Trial Activation Across Latin America - ProPharma

October 20, 2026

Accelerating Clinical Trial Activation Across Latin America

Launching clinical trials across multiple countries requires navigating varying regulatory requirements, site contracts, translations, import/export processes, and site engagement activities, all...

Infographic Flexible Resourcing Without Limits: Scaling Capabilities Across the Development Lifecycle - ProPharma

September 18, 2026

Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...

Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...

Previous Resource Arrow Next Resource Arrow
Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

December 2, 2026

Beyond the Buzz: Leveraging Community Management to Enhance Medical Information

Patients, caregivers, and healthcare professionals are increasingly turning to digital channels to seek information, share experiences, and discuss treatments. Join this webinar to explore how...

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

November 12, 2026

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

October 22, 2026

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Tired of working through lengthy regulatory documents? Join Reg Reels for a concise, video-led look at the latest pharmacovigilance developments from the EMA, FDA, and MHRA. Our experts will...

Previous Webinar Arrow Next Webinar Arrow